Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
Articolo
Data di Pubblicazione:
2014
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Leist, Tp; Comi, Giancarlo; Cree, Ba; Coyle, Pk; Freedman, Ms; Hartung, Hp; Vermersch, P; Casset Semanaz, F; Scaramozza, M; oral cladribine for early MS Study, Group
Link alla scheda completa:
Pubblicato in: